[go: up one dir, main page]

EA200500687A1 - Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли - Google Patents

Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли

Info

Publication number
EA200500687A1
EA200500687A1 EA200500687A EA200500687A EA200500687A1 EA 200500687 A1 EA200500687 A1 EA 200500687A1 EA 200500687 A EA200500687 A EA 200500687A EA 200500687 A EA200500687 A EA 200500687A EA 200500687 A1 EA200500687 A1 EA 200500687A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carboxymethyl
cyano
amino
preparation
carboxylic acid
Prior art date
Application number
EA200500687A
Other languages
English (en)
Other versions
EA007863B1 (ru
Inventor
Яннис Тсудерос
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200500687A1 publication Critical patent/EA200500687A1/ru
Publication of EA007863B1 publication Critical patent/EA007863B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к применению дистронциевой соли 2-[N,N-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500687A 2002-11-05 2003-11-04 Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли EA007863B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213805A FR2846558B1 (fr) 2002-11-05 2002-11-05 Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
PCT/FR2003/003279 WO2004043455A1 (fr) 2002-11-05 2003-11-04 Utilisation du sel distrontique de l'acide 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales

Publications (2)

Publication Number Publication Date
EA200500687A1 true EA200500687A1 (ru) 2005-10-27
EA007863B1 EA007863B1 (ru) 2007-02-27

Family

ID=32104443

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500687A EA007863B1 (ru) 2002-11-05 2003-11-04 Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли

Country Status (26)

Country Link
US (1) US7544710B2 (ru)
EP (1) EP1560578B1 (ru)
JP (1) JP4335146B2 (ru)
KR (1) KR100735348B1 (ru)
CN (1) CN1705479B (ru)
AT (1) ATE328591T1 (ru)
AU (1) AU2003292325B2 (ru)
BR (1) BR0315917A (ru)
CA (1) CA2503975C (ru)
CY (1) CY1105105T1 (ru)
DE (1) DE60305962T2 (ru)
DK (1) DK1560578T3 (ru)
EA (1) EA007863B1 (ru)
ES (1) ES2264010T3 (ru)
FR (1) FR2846558B1 (ru)
GE (1) GEP20084463B (ru)
HK (1) HK1084029A1 (ru)
MA (1) MA27406A1 (ru)
MX (1) MXPA05004792A (ru)
NO (1) NO333599B1 (ru)
NZ (1) NZ539516A (ru)
PL (1) PL214704B1 (ru)
PT (1) PT1560578E (ru)
UA (1) UA78618C2 (ru)
WO (1) WO2004043455A1 (ru)
ZA (1) ZA200503082B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
WO2005123098A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Preventing gastrointestinal side-effects with strontium salts
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6489356B2 (en) * 2000-09-05 2002-12-03 Edward Leung Method for treating pain in humans

Also Published As

Publication number Publication date
PT1560578E (pt) 2006-09-29
GEP20084463B (en) 2008-08-25
DE60305962D1 (de) 2006-07-20
ATE328591T1 (de) 2006-06-15
AU2003292325A1 (en) 2004-06-03
ZA200503082B (en) 2006-07-26
EP1560578A1 (fr) 2005-08-10
CY1105105T1 (el) 2009-11-04
PL375960A1 (en) 2005-12-12
WO2004043455A1 (fr) 2004-05-27
KR100735348B1 (ko) 2007-07-04
JP2006508112A (ja) 2006-03-09
MXPA05004792A (es) 2005-07-22
US20060014824A1 (en) 2006-01-19
CN1705479A (zh) 2005-12-07
KR20050072476A (ko) 2005-07-11
CA2503975A1 (fr) 2004-05-27
CN1705479B (zh) 2010-04-28
EP1560578B1 (fr) 2006-06-07
DE60305962T2 (de) 2007-02-08
US7544710B2 (en) 2009-06-09
NO20052562L (no) 2005-05-26
DK1560578T3 (da) 2006-10-02
JP4335146B2 (ja) 2009-09-30
MA27406A1 (fr) 2005-06-01
PL214704B1 (pl) 2013-09-30
AU2003292325B2 (en) 2008-07-31
CA2503975C (fr) 2010-05-25
HK1084029A1 (en) 2006-07-21
FR2846558A1 (fr) 2004-05-07
FR2846558B1 (fr) 2006-07-14
UA78618C2 (ru) 2007-04-10
NO333599B1 (no) 2013-07-22
ES2264010T3 (es) 2006-12-16
NZ539516A (en) 2007-11-30
EA007863B1 (ru) 2007-02-27
BR0315917A (pt) 2005-09-20

Similar Documents

Publication Publication Date Title
EA200400777A1 (ru) Фармацевтические композиции соединения платины
MXPA04009163A (es) Nuevos compuestos.
SE0101387D0 (sv) Novel compounds
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
RU2600440C3 (ru) Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
AR045317A1 (es) Forma cristalina de agonista dl receptor adrenergico b2
BRPI0410727A (pt) composto, composição farmacêutica, e, uso de um composto
NO20076219L (no) Farmasoytisk formulering med apomorfin for bukkal administrering
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
SE0302546D0 (sv) New compounds
SE0102440D0 (sv) New compound
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
WO2004016741A3 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
SG165397A1 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8- aminocaprylic acid
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
ITRM20030596A1 (it) Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU